Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- AZZ +5.3%, LUNG +2% (also CFO steps down; co guides Q3 revs above consensus), HPQ +1.3% (FY24 guidance, raises div), ASX +1% (Sep revs)
Other news:
- VOXX +9.1% (GNTX to purchase 15.1% stake in VOXX from Avalon Park)
- IMRN +7.6% (achieves record quarterly Travelan sales)
- PLUG +5.6% (preferred supplier of 550 mw PEM electrolyzers to fortescue for proposed Gibson island project)
- STRO +3.8% (Adage Capital Partners discloses 5.86% stake)
- IVZ +3.3% (reports Sept AUM)
- NVO +3% (to stop kidney related FLOW trial FLOW based on interim analysis)
- OBIO +2.8% (stock offering by selling shareholders)
- SILV +2.4% (provides Q3 operational results)
- CVCY +1.8% (Central Valley Bancorp and Community West Bancshares (CWBC) to merge)
- WBA +1.7% (names Tim Wentworth as CEO)
- PXD +1.6% (ExxonMobil (XOM) announces merger with PXD in an all-stock transaction valued at $253/share)
- CIVI +1.2% (stock offering by selling shareholders)
- DHT +1.1% (provides business update for Q3)
- THO +1% (increases dividend)
Analyst comments:
- CAVA +3.5% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- OI +2.7% (upgraded to Equal Weight from Underweight at Barclays)
- BALL +2.4% (upgraded to Overweight from Equal Weight at Barclays)
- PPG +0.9% (upgraded to Overweight from Equal Weight at Barclays)